Jessika Wynendaele joined anacura in 2018 as a Project Manager and a Business Developer to strengthen the cell-based medicinal products division. Prior to joining anacura, Jessika worked as a team leader in a QC department at Pfizer, Belgium, where she and her team were delivering very broad packages of release testing at Pfizer. Jessika was also the training responsible for the entire QC department of more than 200 people, with the focus on efficacy and the right first time attitude. She holds an MSc degree in Biotechnology, obtained from Ghent University, and a PhD degree in Molecular Oncology obtained from K.U.Leuven, Belgium. Jessika's research at KUL was conducted as part of the VIB (Flemish Institute for Biotechnology) and focused on the role of microRNAs regulating tumor suppressors. Her scientific achievements were honoured by the Flemish League against Cancer in 2011. Jessika is a highly-qualified in vitro expert who combines GMP knowledge with advanced biomedical R&D skills in order to bring solid research to the next level.